Covering both basic immunology research and clinical applications, Cellular & Molecular Immunology (CMI) provides the latest information and advancements in our understanding of the immunological response of the host, both in vitro and in vivo. Please go to Aims and scope page for more details.
Cellular & Molecular Immunology is led by Editors-in-Chief Professor Xuetao Cao and Professor Zhigang Tian, please go to ‘about the editors’ page for further information.
Cellular & Molecular Immunology's international Editorial Board spans the breadth of the coverage of the journal –read more about the Editorial Board.
Article metrics such as number of downloads, citations and online attention are available from each article page, and provide an overview of the attention received by a paper.
The 2020 journal metrics for Cellular & Molecular Immunology are as follows:
2 Year Impact Factor: 11.530*
5 Year Impact Factor: 10.635*
JCR Rank*: 12/162(Q1) Immunology
Immediacy Index: 10.939*
Eigenfactor Score: 0.01055*
Article Influence Score: 2.669*
Journal Citation Indicator: 1.50*
Total webpage views, 2020: 1,431,260
Total successful full-text article requests, 2020: 1,660,611
Number of days from Submission to acceptance: 123 days
Number of days from acceptances at publisher to published online: 19 days
*2020 Journal Citation Reports (Clarivate Analytics, 2021)
Journal Citation Reports/Science Edition (Thomson Reuters) (released 2010)
Web of Science/Science Citation Index (Thomson Reuters)
Biological Abstracts (Thomson Reuters)
ISSN and eISSN
The international standard serial number (ISSN) for Cellular & Molecular Immunology is 1672-7681, and the electronic international standard serial number (eISSN) is 2042-0226.
Cellular & Molecular Immunology now provides its latest table of contents as an RSS web feed. This allows users with an RSS reader to receive automatic updates whenever new content is added to these pages.
Find out more about RSS feeds, how to download an RSS reader and see all the news feeds offered by Springer Nature.
The editorial policies of this publication are determined jointly by its Editorial Board and Springer Nature in accordance with the legal and regulatory requirements of China.